Skip to main content
PRCT
NASDAQ Life Sciences

PROCEPT BioRobotics Completes Enrollment in Key Prostate Cancer Study, Gains FDA Approval for New Trial

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$26.515
Mkt Cap
$1.506B
52W Low
$19.35
52W High
$66.85
52W Position info
37% above low
Off High info
60% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

PRCT sits 37% above its 52-week low of $19.35.

Summary

PROCEPT BioRobotics has completed enrollment for its WATER IV RP study, which compares Aquablation therapy to radical prostatectomy for prostate cancer. This is a significant milestone for the company's expansion into the prostate cancer market beyond its current BPH focus. Additionally, the company received FDA IDE approval for a second WATER IV AS study, evaluating Aquablation therapy against active surveillance for lower-risk prostate cancer. While primary endpoint results for the WATER IV RP study are expected in spring 2027, these advancements position the company for potential long-term growth in a larger addressable market.

At the time of this announcement, PRCT was trading at $26.52 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.5B. The 52-week trading range was $19.35 to $66.85. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

PRCT - Latest Insights

PRCT
Nov 04, 2026, 4:50 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $18.06
Real-time Price: $20.27 info
Change: +$2.21 (+12%) info
Market Cap: $1.161B info
PRCT
Nov 04, 2026, 4:06 PM EST
Source: Reuters
Importance Score:
8
Price at Filing: $20.11
Real-time Price: $20.27 info
Change: +$0.160 (+0.80%) info
Market Cap: $1.161B info
PRCT
Aug 04, 2026, 4:12 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $17.57
Real-time Price: $20.27 info
Change: +$2.70 (+15%) info
Market Cap: $1.161B info
PRCT
Aug 04, 2026, 6:36 AM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $18.42
Real-time Price: $20.27 info
Change: +$1.85 (+10%) info
Market Cap: $1.161B info
PRCT
Aug 03, 2026, 7:33 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $18.62
Real-time Price: $20.27 info
Change: +$1.65 (+9%) info
Market Cap: $1.161B info